about
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemiaIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesEvolutionary context for the association of γ-globin, serum uric acid, and hypertension in African Americans.Accuracy of Reverse Dot-Blot PCR in Detection of Different β-Globin Gene MutationsModern treatment of thalassaemia intermedia.Hemoglobin research and the origins of molecular medicine.Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future.Unique pattern of mutations in β-thalassemia patients in Western Uttar Pradesh.Induction of endogenous gamma-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence.Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf areaBeta-thalassemia.Organ targeted prenatal gene therapy--how far are we?Alternative options for DNA-based experimental therapy of β-thalassemia.New updating into hemoglobinopathies.Recent trends for novel options in experimental biological therapy of β-thalassemia.Recent trends in the gene therapy of β-thalassemia.Copy number variations of six and seven α-globin genes in a family with intermedia and major thalassemia phenotypes.Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system.Serum Bcl-2 Levels in Patients with β-Thalassemia Minor: A Pilot Study.Molecular basis of β thalassemia and potential therapeutic targets.Prevalence of hemoglobin E in Yunnan Province of Southwest China.An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production.The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders.Role of iron deficiency anemia in the propagation of beta thalssemia gene.Screening of Five Common Beta Thalassemia Mutations in the Pakistani Population: A basis for prenatal diagnosis.Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin.Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.Pathophysiology and treatment of patients with beta-thalassemia - an update.Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.A comprehensive review of the prevalence of beta globin gene variations and the co-inheritance of related gene variants in Saudi Arabians with beta-thalassemia.Prenatal gene therapy for the early treatment of genetic disorders
P2860
Q24652468-57B7067D-BC38-4E1B-B9E9-0DDA787BD054Q28388335-AAC7B0E5-1188-4D8A-9D5E-5549387249B2Q35873557-7A21A2C0-6F7E-44EB-BF64-99ED328D402FQ36679520-005C006D-F905-4BB0-9489-5C7540017BA6Q36848269-D4637964-FBC1-450D-BC86-7A37941C37EEQ36969792-B5C58395-7451-4143-9361-1002C91D4606Q37024505-2F40A3DB-544A-4B10-8FBE-8874A0F85EA0Q37136077-508E67A6-7BD6-491D-8FC3-4364D34EA18FQ37158682-676CD6D0-DD48-43BF-919B-D32EB32DEB71Q37309900-2940B1FE-547F-4882-B320-598D97CBC485Q37359617-F1C5DF09-4667-47DE-A093-53C954FA81FCQ37680651-829E7BFC-63E1-436E-99E5-1B74DA8E5953Q37880689-FD254860-70DA-4A3E-9F2A-92FB49707CF0Q37993118-5FAAC84D-9563-4FA7-B318-9C1B1F11F63CQ38023896-63D990DB-B3BF-4A99-B434-4053CBB46503Q38220695-7E4A3B28-EC8F-4A58-B045-2976A0197710Q38367473-C3A70D96-959B-4FC1-8604-FC367DEA821EQ38581835-7828F2B2-9195-4898-84B8-510839C87A17Q38892183-7D039549-FF7E-46D4-A892-0A9C2788147DQ39068069-F7DD67FC-8397-4BB2-AB3E-5BD3F8DD7CC7Q39399184-7D9AE2F9-8242-4987-B0E0-53A79CD632E7Q41467048-A35D0581-8757-4574-97F5-EA5B1769AAA9Q41554655-6CF77FC0-E69D-4CBA-B58E-A3432D95F664Q42253045-313A9B98-2CE9-4135-B573-8436FF058BC6Q42704896-BDC8E57C-9EF5-4E18-BDFD-6D5607128EDBQ42714882-ED2D308B-736A-4125-BF9F-E6A624D891E9Q43142280-1CCA77D0-1DED-472E-92D7-9729455D0CB3Q45888439-A1E9D14B-7D61-488F-9672-4E1C978E32DEQ46656153-916FFCC2-5B72-45B9-8310-5AB0086D3C06Q48247015-BFCDF151-247B-4FC7-A7BA-04869AEA3BDFQ52936329-33386F48-7B47-4E8E-961E-87B20EF2F0E3Q53771829-599AFF46-DC12-49A3-967B-49338909E0D3Q55274357-A708BE4C-A4A1-4BA3-8F42-BC2CA00928CAQ56564487-3BEEAB53-EB0C-4554-86E6-FB8DB432A131
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Molecular therapies in beta-thalassaemia.
@ast
Molecular therapies in beta-thalassaemia.
@en
type
label
Molecular therapies in beta-thalassaemia.
@ast
Molecular therapies in beta-thalassaemia.
@en
prefLabel
Molecular therapies in beta-thalassaemia.
@ast
Molecular therapies in beta-thalassaemia.
@en
P2860
P1476
Molecular therapies in beta-thalassaemia.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.2006.06408.X
P407
P577
2006-11-27T00:00:00Z